Sho-saiko-to

Source: Wikipedia, the free encyclopedia.

Shō-saiko-tō (小柴胡湯), also known as minor bupuleurum formula and xiǎocháihútāng (XCHT) (

Memorial Sloan-Kettering Cancer Center. The active ingredients of sho-saiko-to discovered so far include baicalin, baicalein, glycyrrhizin, saikosaponins, ginsenosides, wogonin, and gingerol.[citation needed
]

As a Chinese patent medicine it is listed in the Pharmacopoeia of the People's Republic of China. One dried, soluble form lists chai-hu/saiko (dried Bupleurum chinense or scorzonerifolium root), huangqin (dry Scutellaria baicalensis stem), banxia (Pinellia ternata), ginger, licorice, jujube, and Codonopsis pilosula as ingredients. This form is standardized to contain at least 20 mg baicalin per serving.[1] Some formulae use ginseng instead of C. pilosula.[2]

It is first recorded in Shanghan Lun c. 220 AD, indicated for "lesser yang".[3][4] It has some antidepressant-like effects.[5][6][7][8]

Sho-saiko-to has been studied, but the results in patients with hepatitis B were very low.[9]

References

  1. ISBN 978-7-5067-7337-9
    .
  2. ISBN 978-7-5323-3708-8
  3. PMID 20643590
    .
  4. PMID 18718184
    .
  5. ^ Li, F. M., & Gao, Z. G. (1996). 90 cases of xiaochaihutang treatment for depression in clinical. Shanxi J.Traditional Chin.Med., 10-11."
  6. ^ Jia et al., 2009 C.X. Jia, K.F. Zhang, L. Yu, G.Q. Sun Antidepressant-like effects of Xiaochaihutang on Post stroke depression in clinical Zhejiang J. Tradit. Chin. Med., 44 (2009), pp. 105–106
  7. PMID 24440317
    .
  8. S2CID 20187116
    .
  9. PMID 31697415
    .

Further reading
Retrieved from "https://en.wikipedia.org/w/index.php?title=Sho-saiko-to&oldid=1184182704"